Mayne Pharma Stock Quote MYX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

4.60

Bid

4.52

Ask

4.60

Volume

0.00

0.00 Day's Range 0.00

3.74 52 Week Range 7.46

Market Cap

391.342M

Previous Close

4.60

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

157,520

Shares Outstanding

85,074,288

Dividend Yield

PE Ratio

-2.25

Earnings Per Share (EPS)

-2.05

Revenue

386.19M

Net Profit

-174.23M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.maynepharma.com

Headquarters

Adelaide, South Australia, Aus

Founded

Mayne Pharma Group Ltd is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker MYX. The last closing price for Mayne Pharma was AUD4.60. Over the last year, Mayne Pharma shares have traded in a share price range of AUD 3.74 to AUD 7.46.

Mayne Pharma currently has 85,074,288 shares outstanding. The market capitalization of Mayne Pharma is AUD391.34 million. Mayne Pharma has a price to earnings ratio (PE ratio) of -2.25.

Mayne Pharma Launches Foam Dermatology Products in US

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) said Wednesday it has launched its foam dermatology products Fabior and Sorilux in the U.S., after acquiring the marketing rights from...

Mayne Pharma to buy 42 drugs

/newsletter/barneyc/476/mayne-pharma-to-buy-42-drugs

Mayne Pharma Acquires Rights to a Portfolio of Dermatology Foam Products Including Fabior® and Sorilux®

Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired a portfolio of dermatology foam products and related assets (“Foam Assets”) from GlaxoSmithKline (“GSK”) for US$50.1...

Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) acquired a portfolio of U.S. generic drugs from Teva Pharmaceutical Industries Ltd. (TEVA) and Allergan PLC (AGN) for US$652 million...

Asian Shares Mostly Higher

Australian shares are nearing their highest level since late October on Monday, though falling commodities prices muted gains triggered by stimulus hopes in Europe. The S&P/ASX 200 rose 0.4...

3 stocks in the buy zone and 1 to avoid

http://www.fool.com.au/2015/05/07/3-stocks-in-the-buy-zone-and-1-to-avoid/

Actavis Earnings Soar as Closing of Allergan Deal Looms

By Michael Calia Actavis PLC raised its profit guidance for 2015, while acquisitions again helped drive revenue growth in the fourth quarter, as the company awaits the close of its deal to buy...

Actavis to Divest U.S. Doryx Rights Before Allergan Deal

Actavis PLC (ACT) will sell the U.S. rights to an acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox maker Allergan Inc. The Doryx deal, valued at about...

Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update

By Maria Armental and Robb M. Stewart Actavis PLC (ACT) will sell the U.S. rights to a acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox maker Allergan...

HedgePath Pharmaceuticals Welcomes Three New Board Members

HedgePath Pharmaceuticals Welcomes Three New Board Members Stefan Cross, Dr. Dana Ono and Mark Watson add significant biotechnology, capital markets and public accounting expertise to HPPI's...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.436681222707	4.58	4.64	4.4	75456	4.47438042	DE
4	0	0	4.6	4.97	4.37	101968	4.60614128	DE
12	0.06	1.32158590308	4.54	5.62	4.02	157520	4.7729467	DE
26	-0.07	-1.49892933619	4.67	5.62	3.74	160860	4.65717152	DE
52	-0.5	-9.80392156863	5.1	7.46	3.74	197310	5.34551014	DE
156	4.32	1542.85714286	0.28	7.46	0.19	1495063	0.74578097	DE
260	4.115	848.453608247	0.485	7.46	0.19	2701137	0.48064493	DE

MYX - Frequently Asked Questions (FAQ)

What is the current Mayne Pharma share price?

The current share price of Mayne Pharma is AUD 4.60

How many Mayne Pharma shares are in issue?

Mayne Pharma has 85,074,288 shares in issue

What is the market cap of Mayne Pharma?

The market capitalisation of Mayne Pharma is AUD 391.34M

What is the 1 year trading range for Mayne Pharma share price?

Mayne Pharma has traded in the range of AUD 3.74 to AUD 7.46 during the past year

What is the PE ratio of Mayne Pharma?

The price to earnings ratio of Mayne Pharma is -2.25

What is the cash to sales ratio of Mayne Pharma?

The cash to sales ratio of Mayne Pharma is 1.01

What is the reporting currency for Mayne Pharma?

Mayne Pharma reports financial results in AUD

What is the latest annual turnover for Mayne Pharma?

The latest annual turnover of Mayne Pharma is AUD 386.19M

What is the latest annual profit for Mayne Pharma?

The latest annual profit of Mayne Pharma is AUD -174.23M

What is the registered address of Mayne Pharma?

The registered address for Mayne Pharma is 1538 MAIN NORTH ROAD, SALISBURY SOUTH, ADELAIDE, SOUTH AUSTRALIA, 5106

What is the Mayne Pharma website address?

The website address for Mayne Pharma is www.maynepharma.com

Which industry sector does Mayne Pharma operate in?

Mayne Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1ADAdAlta Limited	AUD 0.018 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.023 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
1ADAdAlta Limited	AUD 0.018 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.023 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
1ADAdAlta Limited	AUD 0.018 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.023 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0